# Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?

> **NCT05217212** · — · UNKNOWN · sponsor: **Luzerner Kantonsspital** · enrollment: 100 (estimated)

## Conditions studied

- Head and Neck Squamous Cell Carcinoma

## Interventions

- **RADIATION:** Radiochemotherapy

## Key facts

- **NCT ID:** NCT05217212
- **Lead sponsor:** Luzerner Kantonsspital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2024-12
- **Final completion:** 2025-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05217212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05217212, "Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05217212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*